Profile data is unavailable for this security.
About the company
TYK Medicines Inc is a China-based company mainly engaged in developing and commercializing pharmaceutical products. The Company is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.
- Revenue in HKD (TTM)0.00
- Net income in HKD-473.77m
- Incorporated2017
- Employees144.00
- LocationTYK Medicines Inc500 Yunjin Road, Greenland VilSHANGHAI 200030ChinaCHN
- Phone+86 2 161676766
- Fax+86 2 160107317
- Websitehttp://www.tykmedicines.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbisko Cayman Ltd | 550.53m | -17.93m | 2.32bn | 275.00 | -- | 1.00 | 633.85 | 4.21 | -0.0304 | -0.0304 | 0.8477 | 3.37 | 0.2159 | -- | 65.75 | 2,133,821.00 | -0.7034 | -- | -0.733 | -- | 0.00 | -- | -3.26 | -- | -- | -- | 0.0142 | -- | -- | -- | 12.92 | -- | -- | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 886.31m | -269.93m | 2.50bn | 1.04k | -- | 3.05 | -- | 2.82 | -0.6778 | -0.6778 | 2.23 | 2.05 | 0.3109 | 23.64 | 5.35 | 831,433.60 | -9.47 | -- | -12.44 | -- | 71.97 | -- | -30.46 | -- | 1.33 | -3.22 | 0.436 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| Alphamab Oncology | 283.27m | -238.72m | 2.72bn | 429.00 | -- | 1.51 | -- | 9.60 | -0.248 | -0.248 | 0.2942 | 1.87 | 0.1145 | 0.8256 | 13.94 | 651,197.70 | -9.65 | -18.72 | -11.16 | -21.94 | 79.33 | -- | -84.27 | -415.55 | 4.42 | -- | 0.167 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Qyuns Therapeutics Co Ltd | 49.73m | -466.97m | 5.37bn | 325.00 | -- | 12.17 | -- | 108.07 | -1.99 | -1.99 | 0.2257 | 1.99 | -- | -- | -- | 150,239.70 | -- | -- | -- | -- | 84.05 | -- | -976.77 | -- | 1.83 | -28.07 | 0.5795 | -- | -- | -- | -70.28 | -- | -- | -- |
| Lepu Biopharma Co Ltd | 227.04m | -80.40m | 5.41bn | 491.00 | -- | 5.34 | 451.89 | 23.81 | -0.0476 | -0.0476 | 0.1364 | 0.592 | 0.0847 | 1.86 | 1.53 | 529,240.40 | -3.53 | -- | -5.72 | -- | 78.76 | -- | -41.62 | -- | 0.7322 | -2.63 | 0.4621 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
| Keymed Biosciences Inc | 90.40m | -822.64m | 10.36bn | 1.12k | -- | 3.55 | -- | 114.65 | -3.15 | -3.15 | 0.3457 | 10.44 | 0.0207 | 0.3115 | 7.74 | 100,777.20 | -18.86 | -- | -20.96 | -- | 68.65 | -- | -909.38 | -- | 4.83 | -- | 0.2155 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
| TYK Medicines Inc | 0.00 | -473.77m | 11.38bn | 144.00 | -- | -- | -- | -- | -1.28 | -1.28 | 0.00 | -3.12 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -68.75 | -- | -- | -100.00 | -- | -22.97 | -- | -- | -- |
| InnoCare Pharma Ltd | 864.33m | -521.32m | 11.47bn | 1.11k | -- | 1.29 | -- | 13.27 | -0.3087 | -0.3087 | 0.5117 | 4.34 | 0.0786 | 0.9875 | 3.19 | 793,694.80 | -4.88 | -13.41 | -6.20 | -15.36 | 85.59 | 85.99 | -62.04 | -172.16 | 3.77 | -- | 0.1667 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
| Ascentage Pharma Group International | 999.73m | -398.87m | 12.20bn | 574.00 | -- | 14.37 | -- | 12.20 | -1.38 | -1.38 | 3.44 | 2.70 | 0.2998 | 3.49 | 2.19 | 1,714,810.00 | -11.97 | -44.93 | -16.78 | -57.04 | 96.96 | 87.68 | -39.93 | -976.10 | 1.83 | -6.44 | 0.6865 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
| RemeGen Co Ltd | 1.55bn | -1.76bn | 12.74bn | 3.50k | -- | 2.44 | -- | 8.24 | -3.27 | -3.27 | 2.87 | 5.42 | 0.2411 | 0.4413 | 6.06 | 427,741.70 | -27.42 | -18.66 | -35.04 | -23.75 | 77.11 | 81.94 | -113.72 | -102.88 | 1.06 | -31.41 | 0.4737 | -- | 40.16 | 148.65 | -51.30 | -- | 59.07 | -- |
| Genscript Biotech Corp | 7.86bn | -1.38bn | 24.05bn | 7.28k | -- | 2.54 | -- | 3.06 | -0.651 | -0.651 | 3.72 | 4.45 | 0.3006 | 9.15 | 7.99 | 1,132,932.00 | -9.68 | -18.34 | -14.76 | -26.15 | 53.63 | 54.68 | -32.19 | -64.91 | 4.06 | -- | 0.1972 | -- | 34.17 | 29.44 | 57.91 | -- | 17.14 | -- |
| Sichuan Kelun-Biotech Biophrmctcl Co Ltd | 2.08bn | -257.71m | 37.73bn | 1.54k | -- | 10.62 | -- | 18.16 | -1.14 | -1.14 | 9.39 | 15.94 | 0.5869 | 9.46 | 167.74 | 1,468,602.00 | -7.28 | -- | -16.56 | -- | 61.81 | -- | -12.40 | -- | 5.59 | -- | 0.0118 | -- | 91.62 | -- | 6.81 | -- | -- | -- |
Data as of Sep 27 2024. Currency figures normalised to TYK Medicines Inc's reporting currency: Hong Kong Dollar HKD
